[[{“value”:”
Microdosing psychedelics, primarily psilocybin and LSD, involve sub-perceptual doses that promote neural pathway development without intense effects. Although traditionally excluded, MDMA is being investigated for its low-dose therapeutic potential, evidenced by a case where microdosed MDMA significantly alleviated neuropathic pain in a cancer survivor, suggesting avenues for future research.
The post Exploring MDMA Microdosing for Pain Relief Benefits appeared first on Psychedelic Integration.
“}]]
Psychedelic Integration Read More
